Posts Slider

Implantable Bioreactor for Kidney Cells
Researchers at the University of California San Francisco have developed an implantable bioreactor that may pave the way for artificial kidneys. Dialysis and kidney transplants...

After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout
Intercept Pharmaceuticals, whose NASH drug candidate went from frontrunner to also-ran, is being acquired for $794 million by an Italian company that sees the biotech’s...

Cartwheel Raises $20M to Tackle The Student Mental Health Crisis
al healthWhat You Should Know: – Cartwheel, a platform helping schools tackle the student mental health crisis by delivering affordable, evidence-based telehealth services with no waitlist...

5 Reasons Why Diversity in Healthcare Leadership Matters
Image source The healthcare industry is rapidly changing. With increasing diversity in patient populations, a focus on health equity, and innovations in healthcare delivery, the...

Intermountain CEO: You Don’t Have To Be a Payvider to Reach Scale in VBC
The value-based care movement has been around for decades, but it’s still struggling to reach real scale. In order to increase the scale of at-risk...
Posts Grid
Implantable Bioreactor for Kidney Cells
Researchers at the University of California San Francisco have developed an implantable bioreactor that may pave the way for artificial kidneys. Dialysis and kidney transplants...
After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout
Intercept Pharmaceuticals, whose NASH drug candidate went from frontrunner to also-ran, is being acquired for $794 million by an Italian company that sees the biotech’s...
Cartwheel Raises $20M to Tackle The Student Mental Health Crisis
al healthWhat You Should Know: – Cartwheel, a platform helping schools tackle the student mental health crisis by delivering affordable, evidence-based telehealth services with no waitlist...
5 Reasons Why Diversity in Healthcare Leadership Matters
Image source The healthcare industry is rapidly changing. With increasing diversity in patient populations, a focus on health equity, and innovations in healthcare delivery, the...
Intermountain CEO: You Don’t Have To Be a Payvider to Reach Scale in VBC
The value-based care movement has been around for decades, but it’s still struggling to reach real scale. In order to increase the scale of at-risk...
MedCity Pivot Podcast: Tackling Rare Disease With Someone Who Was Touched By It
In this last episode of Season 3 of the MedCity Pivot Podcast — focused on Transforming the Life Sciences — we take a look at...